SK283845B6 - Použitie špecifického antagonistu receptora 5HT2 na prípravu liečiv použiteľných na liečenie syndrómu krátkodobého zastavenia dýchania v spánku - Google Patents

Použitie špecifického antagonistu receptora 5HT2 na prípravu liečiv použiteľných na liečenie syndrómu krátkodobého zastavenia dýchania v spánku Download PDF

Info

Publication number
SK283845B6
SK283845B6 SK1845-99A SK184599A SK283845B6 SK 283845 B6 SK283845 B6 SK 283845B6 SK 184599 A SK184599 A SK 184599A SK 283845 B6 SK283845 B6 SK 283845B6
Authority
SK
Slovakia
Prior art keywords
sleep
hydroxyphenyl
prop
dimethylaminoethyl
fluorophenyl
Prior art date
Application number
SK1845-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK184599A3 (en
Inventor
Fran�Oise Cattelin
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of SK184599A3 publication Critical patent/SK184599A3/sk
Publication of SK283845B6 publication Critical patent/SK283845B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1845-99A 1997-06-26 1998-06-02 Použitie špecifického antagonistu receptora 5HT2 na prípravu liečiv použiteľných na liečenie syndrómu krátkodobého zastavenia dýchania v spánku SK283845B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9707998A FR2765107B1 (fr) 1997-06-26 1997-06-26 Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil
PCT/FR1998/001100 WO1999000119A1 (fr) 1997-06-26 1998-06-02 Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil

Publications (2)

Publication Number Publication Date
SK184599A3 SK184599A3 (en) 2000-06-12
SK283845B6 true SK283845B6 (sk) 2004-03-02

Family

ID=9508467

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1845-99A SK283845B6 (sk) 1997-06-26 1998-06-02 Použitie špecifického antagonistu receptora 5HT2 na prípravu liečiv použiteľných na liečenie syndrómu krátkodobého zastavenia dýchania v spánku

Country Status (29)

Country Link
US (1) US6143792A (no)
EP (1) EP1014960B1 (no)
JP (1) JP3503953B2 (no)
KR (1) KR20010014186A (no)
CN (1) CN1154485C (no)
AT (1) ATE232094T1 (no)
AU (1) AU728227B2 (no)
BG (1) BG104038A (no)
BR (1) BR9810337A (no)
CA (1) CA2295119C (no)
CZ (1) CZ291935B6 (no)
DE (1) DE69811248T2 (no)
EE (1) EE9900595A (no)
ES (1) ES2191942T3 (no)
FR (1) FR2765107B1 (no)
HK (1) HK1028351A1 (no)
HU (1) HU229058B1 (no)
ID (1) ID23799A (no)
IL (1) IL133632A (no)
IS (1) IS2356B (no)
NO (1) NO325520B1 (no)
NZ (1) NZ502495A (no)
PL (1) PL190723B1 (no)
RU (1) RU2218917C2 (no)
SK (1) SK283845B6 (no)
TR (1) TR199903197T2 (no)
TW (1) TW580386B (no)
UA (1) UA59397C2 (no)
WO (1) WO1999000119A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
WO1999043319A1 (en) 1998-02-27 1999-09-02 The Board Of Trustees Of The University Of Illinois Agents with serotonin-related activity for the treatment for sleep apnea
FR2787328A1 (fr) 1998-12-22 2000-06-23 Sanofi Sa Utilisation d'un antagoniste des recepteurs 5ht2a pour la preparation de medicaments utiles dans le traitement des ronflements et du syndrome de haute resistance ou de resistance des voies aeriennes superieures
WO2000051582A2 (en) * 1999-03-01 2000-09-08 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
FR2804604B1 (fr) * 2000-02-09 2005-05-27 Sanofi Synthelabo Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles pour faciliter l'arret de la consommation de tabac
DK1534391T3 (da) * 2002-07-19 2007-06-11 Biovitrum Ab Nye piperazinyl-pyrazinonderivater til behandling af 5-HT2A-recptor-relaterede forstyrrelser
AU2005319367B2 (en) * 2004-12-20 2012-05-24 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
WO2010055461A1 (en) * 2008-11-13 2010-05-20 Sanofi-Aventis Method of treating sleep disorders using eplivanserin
EP2266554A1 (en) * 2009-05-26 2010-12-29 Sanofi-Aventis Method of treating sleep disorders using eplivanserin
EP2186511A1 (en) * 2008-11-13 2010-05-19 Sanofi-Aventis Method of treating sleep disorders using eplivanserin
WO2010079241A1 (es) 2009-01-12 2010-07-15 Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion Uso de antagonistas y/o agonistas inversos de los receptores cb1 para la preparación de medicamentos que incrementen la excitabilidad de las motoneuronas
EP2255726A1 (en) 2009-05-26 2010-12-01 Sanofi-Aventis Spectral profile of SWS enhancing drugs
EP2255807A1 (en) 2009-05-26 2010-12-01 Sanofi-Aventis Method of treating sleep disorders using the combination of eplivanserin and zolpidem
EP2269600A1 (en) * 2009-07-02 2011-01-05 Sanofi-Aventis Treatment of sleep disorders using eplivanserin in COPD patients

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
ZA912278B (en) * 1990-03-29 1992-11-25 Lilly Co Eli Compounds affecting serotonin receptors
EP0517984A1 (en) * 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines

Also Published As

Publication number Publication date
ID23799A (id) 2000-05-11
EE9900595A (et) 2000-08-15
IL133632A (en) 2003-10-31
CN1265586A (zh) 2000-09-06
KR20010014186A (ko) 2001-02-26
HK1028351A1 (en) 2001-02-16
SK184599A3 (en) 2000-06-12
UA59397C2 (uk) 2003-09-15
PL337871A1 (en) 2000-09-11
CA2295119A1 (en) 1999-01-07
TR199903197T2 (xx) 2000-05-22
NO996442L (no) 2000-02-28
IL133632A0 (en) 2001-04-30
EP1014960B1 (fr) 2003-02-05
PL190723B1 (pl) 2005-12-30
CZ469599A3 (cs) 2000-04-12
FR2765107B1 (fr) 2000-03-24
DE69811248D1 (de) 2003-03-13
JP3503953B2 (ja) 2004-03-08
IS5316A (is) 1999-12-21
IS2356B (is) 2008-04-15
CA2295119C (en) 2007-02-13
FR2765107A1 (fr) 1998-12-31
BR9810337A (pt) 2000-09-05
JP2001520678A (ja) 2001-10-30
HU229058B1 (en) 2013-07-29
AU8024398A (en) 1999-01-19
RU2218917C2 (ru) 2003-12-20
AU728227B2 (en) 2001-01-04
NZ502495A (en) 2000-10-27
EP1014960A1 (fr) 2000-07-05
HUP0002170A2 (hu) 2001-11-28
WO1999000119A1 (fr) 1999-01-07
US6143792A (en) 2000-11-07
TW580386B (en) 2004-03-21
NO996442D0 (no) 1999-12-23
CZ291935B6 (cs) 2003-06-18
NO325520B1 (no) 2008-06-02
BG104038A (en) 2001-04-30
ATE232094T1 (de) 2003-02-15
ES2191942T3 (es) 2003-09-16
CN1154485C (zh) 2004-06-23
HUP0002170A3 (en) 2001-12-28
DE69811248T2 (de) 2003-12-04

Similar Documents

Publication Publication Date Title
KR101125462B1 (ko) 모다피닐의 제약 제제
SK283845B6 (sk) Použitie špecifického antagonistu receptora 5HT2 na prípravu liečiv použiteľných na liečenie syndrómu krátkodobého zastavenia dýchania v spánku
JP2000507544A (ja) 痛みの治療方法
JP4048024B2 (ja) 新規経口製剤
AU1217697A (en) Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
ES2238781T3 (es) Utilizacion de la mirtazapina para la obtencion de un medicamento para el tratamiento de las apneas del sueño.
JP2002542281A (ja) あらゆる気分障害、適応障害または不安−抑うつ混合障害の治療または予防に有用な医薬の調製のためのサレドゥタントおよび医薬として許容されるその塩類の使用
US6008222A (en) Method for oral administration of buspirone and nefazodone
JP4542777B2 (ja) 肺高血圧症を予防または治療するのに用いられる医薬の製造のためのイルベサルタンの使用
KR20020038946A (ko) 미르타자핀을 포함한 경구 붕해성 조성물
US6576670B1 (en) Use of a 5HT2A and 5HT2A/C receptor antagonist for treating snoring and high resistance syndrome of upper anatomical airways
JP7270901B2 (ja) 男性の避妊のための非ホルモン性組成物および方法
JP2008522955A (ja) リピド・リッチ・プラークの縮小、安定化及び破裂予防方法
MXPA99012044A (en) Use of a specific antagonist of 5ht2
MXPA01006464A (en) Use of a 5ht2a and 5ht2a/c receptor antagonist for preparing medicines for treating snoring and high resistance syndrome of upper anatomical airways
JP2011088858A (ja) 経口医薬組成物
WO2004080487A1 (ja) 歯ぎしりの予防剤または治療剤

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20140602